| Product NDC: | 50111-917 |
| Proprietary Name: | Torsemide |
| Non Proprietary Name: | Torsemide |
| Active Ingredient(s): | 20 mg/1 & nbsp; Torsemide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50111-917 |
| Labeler Name: | Pliva, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076346 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040601 |
| Package NDC: | 50111-917-03 |
| Package Description: | 1000 TABLET in 1 BOTTLE (50111-917-03) |
| NDC Code | 50111-917-03 |
| Proprietary Name | Torsemide |
| Package Description | 1000 TABLET in 1 BOTTLE (50111-917-03) |
| Product NDC | 50111-917 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Torsemide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20040601 |
| Marketing Category Name | ANDA |
| Labeler Name | Pliva, Inc |
| Substance Name | TORSEMIDE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |